Dying and profits: The evolution of hospice

The influx of for-profit companies into the hospice field has benefited patients, advocates say, because the commercial companies made big investments in technology, focused on efficiency and made care more accessible. But a Washington Post analysis of hundreds of thousands of U.S. hospice records indicates that, as those companies transformed a movement once dominated by […]

Some Observations Related to the Generic Drug Market

The incentive for a manufacturer of a brand-name prescription drug to undertake measures that attempt to prolong the period of marketing exclusivity for a brand-name drug is very strong. For most prescription drug products, incremental production costs are quite low—literally pennies a pill—while successful new drugs can command high prices. The period of a drug’s […]